beta

APM

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Market Cap:

Primary Exchange:

Website: /stocks/apm

Shares Outstanding:

Float:

Dividend: (%)

Beta:

Sector:

Industry:

Short Interest ():

Ethical Flags

Longest drawdown: 16 trading days

From: 2018-12-24 To: 2019-01-17

Lowest Point:

Week In Review: $1.5 Billion In China Deals With One Week Left In 2018

via: SeekingAlpha at 2018-12-23 08:57:55:000

Deals and Financings Xynomic Pharma, a US-China oncology company, has acquired a worldwide license to an mTORC1/2 inhibitor developed by Boehringer Ingelheim in exchange for an $800 million package of upfront, milestone and royalty payments. BI has completed a successful Phase I trial of B… read more...

Week In Review: $1.5 Billion In China Deals With One Week Left In 2018

via: SeekingAlpha at 2018-12-23 08:57:55:000

Deals and Financings Xynomic Pharma, a US-China oncology company, has acquired a worldwide license to an mTORC1/2 inhibitor developed by Boehringer Ingelheim in exchange for an $800 million package of upfront, milestone and royalty payments. BI has completed a successful Phase I trial of B… read more...

Week In Review: $1.5 Billion In China Deals With One Week Left In 2018

via: SeekingAlpha at 2018-12-23 08:57:55:000

Deals and Financings Xynomic Pharma, a US-China oncology company, has acquired a worldwide license to an mTORC1/2 inhibitor developed by Boehringer Ingelheim in exchange for an $800 million package of upfront, milestone and royalty payments. BI has completed a successful Phase I trial of B… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX